How big is the Non-opioid Pain Patch Market?

The Non-opioid Pain Patch Market size is expected to reach USD 3.59 billion in 2024 and grow at a CAGR of 3% to reach USD 4.16 billion by 2029. Read More

What is the current Non-opioid Pain Patch Market size?

In 2024, the Non-opioid Pain Patch Market size is expected to reach USD 3.59 billion. Read More

Who are the key players in Non-opioid Pain Patch Market?

Endo Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co. Inc., Teva Pharmaceuticals Industries Ltd., Veridian Healthcare and Sanofi are the major companies operating in the Non-opioid Pain Patch Market. Read More

Which is the fastest growing region in Non-opioid Pain Patch Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Non-opioid Pain Patch Market?

In 2024, the North America accounts for the largest market share in Non-opioid Pain Patch Market. Read More

What years does this Non-opioid Pain Patch Market cover, and what was the market size in 2023?

In 2023, the Non-opioid Pain Patch Market size was estimated at USD 3.48 billion. The report covers the Non-opioid Pain Patch Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Non-opioid Pain Patch Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Non-opioid Pain Patch Market Share

Statistics for the 2023 & 2024 Non-opioid Pain Patch market share, created by Mordor Intelligence™ Industry Reports. Non-opioid Pain Patch share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Non-opioid Pain Patch Industry

The market is fragmented, with fierce competition between existing players and new entrants. Various market players use different technologies to develop products that facilitate effective and prolonged drug release to increase consumer base and product penetration. Some of the market players are Endo Pharmaceuticals, Hisamitsu Pharmaceutical, Sanofi, Sorrento Therapeutics (SCILEX Pharmaceuticals), and TEH SENG Pharmaceutical Mfg. Co. Ltd, Teikoku Seiyaku Co. Ltd, Teva Pharmaceuticals, and Veridian Healthcare.